Studies have suggested that p21cip1 expression promoted tumor regression and poor prognosis in 112 cancer patients [36, 37], but other studies reported that p21cip1 expression reduces stem cell properties [38, 39]. The gene discussed is CDKN1A; the disease is neoplasm.